We are live on ! Find out more
ELTX icon

Elicio Therapeutics

47 hedge funds and large institutions have $69.3M invested in Elicio Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 4

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

15% more funds holding

Funds holding: 4147 (+6)

4% more capital invested

Capital invested by funds: $66.5M → $69.3M (+$2.81M)

0.68% more ownership

Funds ownership: 1.7%2.38% (+0.68%)

Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
22
Reduced
4
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CG
26
Caprock Group
Idaho
$154K
SPIA
27
Steward Partners Investment Advisory
New York
$152K +$168K +1,556 New
Deutsche Bank
28
Deutsche Bank
Germany
$138K +$114K +1,059 +298%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$124K +$137K +1,270 New
AIG
30
American International Group
New York
$116K +$93.7K +867 +267%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$115K +$40.1K +371 +46%
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$114K +$127K +1,171 New
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$107K +$118K +1,095 New
MIM
34
MetLife Investment Management
New Jersey
$95.8K +$106K +981 New
MLICM
35
Metropolitan Life Insurance Company (MetLife)
New York
$72.5K +$80.2K +742 New
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$56K +$108 +1 +0.2%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$26K +$24.7K +229 +573%
Citigroup
38
Citigroup
New York
$24K +$23.8K +220 +786%
Osaic Holdings
39
Osaic Holdings
Arizona
$23K +$25.2K +233 New
Legal & General Group
40
Legal & General Group
United Kingdom
$22K +$18.4K +170 +298%
AIP
41
Ameritas Investment Partners
Nebraska
$16K +$13K +120 +255%
TRCT
42
Tower Research Capital (TRC)
New York
$11K +$432 +4 +4%
Wells Fargo
43
Wells Fargo
California
$2K +$864 +8 +80%
TFA
44
Toth Financial Advisory
Virginia
$1K
S
45
SignatureFD
Georgia
$1K +$648 +6 New
US Bancorp
46
US Bancorp
Minnesota
$1K +$1.19K +11 New
HF
47
HRT Financial
New York
-$779K -5,986 Closed
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
-$744K -5,715 Closed
Millennium Management
49
Millennium Management
New York
-$626K -4,806 Closed
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
-$420K -3,224 Closed

ELTX Hedge Fund Activity: Q3 2021 in Review

47 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q3 2021, worth a combined $69.3M — up 4.2% from $66.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ELTX positions and 8 closed out — a net gain of 6 holders — while 22 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $7.96M. The largest seller was HRT Financial, exiting entirely with an estimated $779K sold.

  • 47 institutional investors held Elicio Therapeutics (ELTX) as of Q3 2021, up from 41 in Q2 2021.
  • Funds reported $69.3M of Elicio Therapeutics stock for Q3 2021, up 4.2% quarter-over-quarter.
  • 14 funds opened new Elicio Therapeutics positions in Q3 2021 and 8 closed out, a net change of +6 holders.
  • The largest Elicio Therapeutics buyer in Q3 2021 was BlackRock, an estimated $7.96M added.
  • The largest Elicio Therapeutics seller in Q3 2021 was HRT Financial, an estimated $779K sold.

Based on aggregated 13F filings for Q3 2021.